IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE: A PHASE 2 STUDY ANALYSIS USING THE SF-36

Vipul Jairath  1     Toshifumi Hibi  2     Lai Shan Chan  3     Theresa Hunter Gibble     Hilde Carlier     Xian Zhou  4     Marijana Protic     David T. Rubin  5    
1 Western University & London Health Sciences Centre, Ontario
2 Kitasato Institute Hospital IBD Research and Treatment, Tokyo, Japan
3 Eli Lilly and Company, Indianapolis, United States
4 Syneos Health, Morrisville, United States
5 University of Chicago Medicine, Chicago, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing